Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia.

Prouvot, Catherine; Golfier, François; Massardier, Jérôme; You, Benoit; Lotz, Jean-Pierre; Patrier, Sophie; Devouassoux, Mojgan; Schott, Anne-Marie; Hajri, Touria; Bolze, Pierre-Adrien

Prouvot, Catherine; Golfier, François; Massardier, Jérôme; You, Benoit; Lotz, Jean-Pierre; Patrier, Sophie; Devouassoux, Mojgan; Schott, Anne-Marie; Hajri, Touria; Bolze, Pierre-Adrien.

Afiliación

Prouvot C; Department of Gynecological Surgery and Oncology, Obstetrics, University Hospital Lyon Sud, University of Lyon 1.
Lotz JP; Department of Medical Oncology, Alliance for Cancer Research, Tenon Hospital, Public Assistance Hospitals of Paris, Paris.
Patrier S; Department of Pathology, University Hospital of Rouen, Rouen.
Devouassoux M; Department of Pathology Croix Rousse Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1.
Hajri T; French Centre for Trophoblastic Diseases, University Hospital Lyon Sud, Pierre Bénite.

Int J Gynecol Cancer ; 28(5): 1038-1044, 2018 06.

Article en En | MEDLINE | ID: mdl-29629964

Asunto(s)

Antibióticos Antineoplásicos/uso terapéutico; Dactinomicina/uso terapéutico; Enfermedad Trofoblástica Gestacional/tratamiento farmacológico; Adulto; Antimetabolitos Antineoplásicos/uso terapéutico; Femenino; Humanos; Metotrexato/uso terapéutico; Embarazo; Estudios Retrospectivos; Insuficiencia del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dactinomicina / Enfermedad Trofoblástica Gestacional / Antibióticos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google